CIK 0001158780
- Non-accelerated filer
- Smaller reporting company
Pluri Inc.
Sign in to watch- Ticker
- PLUR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 980351734
- Phone
- +972 747107171
- Business address
- MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, Israel
- Former names
- PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 100,000 shares (grant or award)
- 4 Grant or award CEO & President acquired 1,000,000 shares (grant or award)
- 4 Grant or award Executive Chairman acquired 1,000,000 shares (grant or award)
- 4 Open-market buy 10% owner bought 65,771 shares at an average $9.24 ($607,924)
- 4 Open-market buy 10% owner bought 121,926 shares at $9.03 ($1,100,992)
- 4 Open-market buy 10% owner bought 81,198 shares at $8.46 ($686,935)
- 4 Open-market buy 10% owner bought 49,396 shares at $8.34 ($411,963)
- 4 Open-market buy 10% owner bought 199,686 shares at an average $8.04 ($1,604,865)
- 4 Open-market buy 10% owner bought 700,449 shares at an average $7.61 ($5,328,131)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 14,286 shares at $0.70 ($10,000)
- 4 Open-market buy Co-CEO & Chairman bought 71,429 shares at $0.70 ($50,000)
- 4 Open-market buy Co-CEO & President bought 71,429 shares at $0.70 ($50,000)
- 4 Open-market buy Director bought 71,429 shares at $0.70 ($50,000)
- 4 Open-market buy Director bought 28,571 shares at $0.70 ($20,000)
- 4 Open-market buy Director bought 50,000 shares at $0.70 ($35,000)
Page 4 of 18 · 352 filings